Before and After screenshot of the filing status of

New Post Public Reply Private Reply Replies (0) Message Board
joey68
227
Before and After screenshot of the filing status of ICNB!

PXi4HHK.png

Click -> Post #488 written PRIOR to the stop sign being taken down. THAT is how predictable icnb is!

Iconic Brands, Inc. (ICNB) Stock Research Links

ICNB Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mastering Dumpster Choices for Home Projects in Roseburg

Updated Category News Views 8

The Art of Choosing the Right Dumpster When you're up against a home cleanout or remodel, the dumpster's a hero you didn't know you needed. For folks in Roseburg, Oregon, this comes down to the savvy words of Dori John, a waste management expert who's got the lowdown on dumpster decision-making. Think you can just guess how big a container you need by eyeballing your...

Continue Reading
Infotech's 2027 Trends: AI Reshapes Strategy & Risk

Updated Category News Views 53

AI's Growing Footprint in Global Strategies Let's get straight to it: AI's not just playing in the background anymore—it's front and center, dipping its fingers into everything from budget spreadsheets to boardroom agendas. Infotech's annual Tech Trends 2027 report isn't mincing words about AI either, spotlighting 14 trends across four themes that tech leaders better be...

Continue Reading
Perfect Companion Expands Amid Ohio's Growing Elderly Needs

Updated Category News Views 12

Riding the Aging Wave in Columbus The Perfect Companion is no stranger to the ups and downs of the eldercare industry. Celebrating five years in Columbus, this eldercare outfit's trying to pull off what many can't—a solid expansion in a landscape where finding reliable home care employees is about as easy as pulling teeth. But here they are, aiming to hire 25 more...

Continue Reading
OneQode & AdaniConneX Forge AI Path in India

Updated Category News Views 0

A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....

Continue Reading
China's Capital Markets Eye Transformation 2026-2030

Updated Category News Views 25

China's Capital Markets: A New Era Dawns Guosen Securities is ringing the bell for a fundamental shift in China's capital markets, folks. As we're about to roll into the 15th Five-Year Plan period, they're not just talking about expansion anymore. Nope, it's all about reshaping the landscape with regulatory reforms, innovation, and international integration. If you think...

Continue Reading
Beta Bionics Lawsuit: What Investors Need to Know

Updated Category News Views 43

Beta Bionics Takes a Hit: What's Behind the Drop? You ever have one of those moments where you wonder if you missed a memo? Well, folks investing in Beta Bionics (NASDAQ:BBNX) sure might feel that way after a staggering 37% plunge in their stock. The issue here isn't just the drop—it's what spurred it: a securities class action lawsuit alleging some murky disclosures...

Continue Reading
Altea Targets US Market, Appoints Rodrick VP Amid Expansion

Updated Category News Views 58

Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...

Continue Reading
Patriot Growth Welcomes Rajeev Jain: Operational Excellence

Updated Category News Views 71

Shifting Gears: Patriot Growth's New Leadership Turn When it comes to tightening the ship and pointing towards uncharted waters, new leadership can be the key. This couldn't be more true for Patriot Growth Insurance Services as they welcome Rajeev Jain aboard as their latest Chief Operating Officer. This move is all about reinforcing their commitment to operational...

Continue Reading
Bracco's $230M U.S. Expansion: A Strategic Leap

Updated Category News Views 59

Bracco's Bold Move into U.S. Manufacturing In the bustling world of diagnostic imaging, Bracco's latest announcement is like a welcome jolt. They're shelling out $230 million for a new manufacturing facility in Sanford, North Carolina. If you've been around the block in this sector, this move screams ambition—Bracco's playing the long game here. Strategic Location: A...

Continue Reading
Exploring Manual Lymphatic Massage: Key Benefits & Insights

Updated Category News Views 35

The Surge in Popularity of Manual Lymphatic Massage There's a whole lotta buzz around manual lymphatic drainage (MLD) these days, and folks want to know if all that hype's got any juice. During National Massage Therapy Awareness Week, the American Massage Therapy Association (AMTA) lent a hand by spotlighting what the latest research has to say about this specialized...

Continue Reading

Top 5 Most Recently Viewed Articles

CompTIA's Cybersecurity Viability Session at TechNet Augusta

Updated Category News Views 167

CompTIA's Upcoming Session at TechNet Augusta Conference CompTIA is set to present a significant session at the upcoming TechNet Augusta conference, focusing on how people, data, and artificial intelligence (AI) can come together to enhance the readiness of cybersecurity. This session is an integral part of the CompTIA Learning Solutions Series, scheduled for a day...

Continue Reading
Laura Mercier Launches on Amazon: A New Era of Beauty

Updated Category News Views 2524

Laura Mercier Launches on Amazon Premium Beauty Award-winning beauty brand Laura Mercier has officially launched on the Amazon U.S. Premium Beauty Store, enhancing accessibility to high-quality beauty products. Renowned for its artistry-inspired makeup and skincare lines, Laura Mercier is now joining forces with Amazon, making it easier for beauty enthusiasts everywhere...

Continue Reading
Truist Adjusts Merck's Stock Target Amid Acquisition Insights

Updated Category News Views 121

Truist Adjusts Merck's Price Target Recently, Truist Securities revised its price target for Merck & Co., Inc. (NYSE:MRK) from $143.00 down to $132.00. Despite this adjustment, they continue to maintain a Buy rating for the stock, showcasing their confidence in its long-term potential. Impact of the Recent Acquisition This downgrade comes on the heels of Merck's...

Continue Reading
Xilio Therapeutics Expands Team with Stock Options Grant

Updated Category News Views 174

Xilio Therapeutics Expands Team with Stock Options Grant Xilio Therapeutics, Inc. (Nasdaq: XLO), a cutting-edge biotechnology firm focused on developing tumor-activated immuno-oncology therapies, is making significant strides in its mission to support those living with cancer. In an exciting development, the company has announced the granting of a non-qualified stock...

Continue Reading
Crunching the Numbers: Navigating Portugal’s Mortgage Landscape for Smart Investments

Updated Category Investing Views 527

For the analytical investor, every property acquisition begins with the numbers. In Portugal, a market celebrated for its steady growth and robust financial incentives, understanding mortgage dynamics is essential to making sound investment decisions. You might find that a deep dive into Portugal’s mortgage landscape reveals both challenges and substantial...

Continue Reading